Clinical Evaluation of Patients with Benign Prostatic Hyperplasia Grade ii in a Family Medicine Unit

• Autores: David Evaristo Jiménez Tlatenchi, Juan Edgardo García González, Alfonso Zempoalteca Morales
• Localización: Atención familiar: Órgano de difusión científica del Departamento de Medicina Familiar, ISSN 1405-8871, Vol. 28, Nº. 1, 2021, págs. 33-37
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Objective: to evaluate the clinical evolution of patients with Benign Prostatic Hyperplasia grade ii in the Family Medicine Unit (fmu) No. 77. Methods: longitudinal study conducted from January to October 2019, 206 patients selected by a systematized random sampling, diagnosed with Benign Prostatic Hyperplasia grade ii, without a history of surgery of the urinary system; the International Prostatic Symptom Score (ipss) was used on three occasions (zero, three and six months) to evaluate the evolution of prostatic symptoms. Measures of central tendency were used for the descriptive analysis, and the McNemar test to compare results. Results: in the first application 174 patients presented mild symptoms, 29, moderate symptoms, and 3, severe symptoms; in the second application 172 presented mild symptoms, 34, moderate symptoms, and none presented severe symptoms; in the third application 174, presented mild symptoms, 26, moderate symptoms, and 6 severe symptoms. The McNemar test was not statistically significant when comparing the three results. Conclusions: most of the studied patients in treatment maintained stable prostate symptoms.